Name: What's next for biotech after JPM 2026? Tomorrow, join Endpoints News and leaders from Precision For Medicine and Precision AQ for a forward-looking discussion on the trends reshaping drug… | Precision Medicine Group
Uploaded: 2025-11-11T18:19:16.780Z
Duration: 36 s
Channel: Precision Medicine Group
Description: What's next for biotech after JPM 2026? Tomorrow, join Endpoints News and leaders from Precision For Medicine and Precision AQ for a forward-looking discussion on the trends reshaping drug development and commercialization. Our Chief Medical Officer, Harpreet Singh, MD shares a quick preview below. November 12 | 2:30 PM ET https://hubs.ly/Q03S5Nvy0

Precision Medicine Group

316,981 followers

What's next for biotech after JPM 2026? Tomorrow, join Endpoints News and leaders from Precision For Medicine and Precision AQ for a forward-looking discussion on the trends reshaping drug development and commercialization. Our Chief Medical Officer, Harpreet Singh, MD shares a quick preview below. November 12 | 2:30 PM ET https://hubs.ly/Q03S5Nvy0

Transcript

I'm Harpreet Singh, Chief Medical Officer at Precision for Medicine, and I'll be participating in the Endpoints webinar from JP Morgan to the next Wave. What's driving biotech in 2026? On November 12th. I'm very excited to talk about regulatory strategies and clinical trials and tell partnering with a group like Precision can help companies take their molecule to market, supporting them each step in the developmental and commercialization. 30 Register in the link below. Can't wait to share the stage with my Precision colleagues.

To view or add a comment, sign in

Explore content categories